CRBP

SEC filing CRBP Appoints Evercore Exec Nishant Saxena CBO, Pre-2026 ASCO Data Shows CRB-701 Durable Responses in HNSCC, Cervical Cancer; CRB-913 Phase 1b Complete

12d ago

SEC filing CRBP Amends Exec Agreements: Cohen Base $673.6K, 60% Bonus Target, 2-Yr Term; Moran Base $501.3K, 40% Bonus Target, 2-Yr Term

46d ago

SEC filing CRBP Reports $75M Offering, $19.3M Net Income, +94% YoY, CRB-701 47.6% ORR, CRB-913 2.9% Weight Loss

85d ago

Insider trade Sale by Dominic Smethurst (Chief Medical Officer)

89d ago

Insider trade Sale by Sean F. Moran

103d ago

Insider trade Sale by Dominic Smethurst (Chief Medical Officer)

104d ago

Insider trade Sale by Ian Hodgson (Chief Operating Officer)

104d ago

News Corbus Pharmaceuticals Announces Pricing of Public Offering

153d ago

News Corbus Pharmaceuticals Announces Pricing of Public Offering

153d ago

Scanner Unusual volume (z=39.8)

171d ago